Health In Tech grants CEO 1.5M-share milestone award
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Health In Tech, Inc. (HIT) CEO Sanjay K. Shrestha received restricted Class A stock awards on November 10, 2026: 1,500,000 shares in MC-2, 500,000 shares in MC-3 and 500,000 shares in MC-4. The grants became effective upon stockholder approval of a plan amendment that day. Each tranche is automatically forfeited without consideration unless the issuer’s market capitalization, based on a 10-day volume-weighted average price, exceeds its respective threshold by its deadline: MC-2, $300 million by December 31, 2028; MC-3, $500 million by December 31, 2029; and MC-4, $1 billion by December 31, 2031. After its threshold is met, each tranche vests in 12 equal monthly installments, subject to continued service.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A Common Stock F1 | 1,500,000 | $0.00 | $0.00 |
| Grant/Award | Class A Common Stock F2 | 500,000 | $0.00 | $0.00 |
| Grant/Award | Class A Common Stock F3, F4 | 500,000 | $0.00 | $0.00 |
Footnotes (4)
- F1. Represents restricted shares of Class A Common Stock (the "MC-2 Tranche") granted pursuant to a Restricted Stock Award Agreement dated October 20, 2026 under the Health In Tech, Inc. Equity Incentive Plan (the "Plan"), the grant of which was contingent upon, and became effective upon, stockholder approval of an amendment to the Plan at the Issuer's 2026 Annual Meeting of Stockholders on November 10, 2026. The shares will be automatically forfeited without consideration unless the Issuer's market capitalization, based on the 10-day volume-weighted average price, exceeds $300 million on or before December 31, 2028 (the "Achievement Date"). Thereafter, the shares vest in twelve equal monthly installments, subject to continued service. If the Achievement Date falls before the 15th calendar day of the month, vesting commences on such 15th day, and if after, commences on the 1st day of the next calendar month.
- F2. Represents restricted shares of Class A Common Stock (the "MC-3 Tranche") granted on the same basis as described in footnote (1), except that the market capitalization threshold is $500 million and the deadline is December 31, 2029.
- F3. Represents restricted shares of Class A Common Stock (the "MC-4 Tranche") granted on the same basis as described in footnote (1), except that the market capitalization threshold is $1 billion and the deadline is December 31, 2031.
- F4. Includes 7,500,000 restricted shares of Class A Common Stock and 101,200 unrestricted shares of Class A Common Stock. Excludes 500,000 restricted shares of Class B Common Stock previously reported. All unvested restricted shares held by the reporting person vest in full upon a Change in Control (as defined in the reporting person's Employment Agreement).
Key Figures
Key Terms
Restricted Stock Award Agreement technical
Equity Incentive Plan technical
10-day volume-weighted average price financial
Achievement Date financial
Change in Control technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What market-capitalization targets apply to the HIT CEO's stock awards?
How do Sanjay K. Shrestha's HIT stock awards vest?
AI-generated analysis. How Rhea-AI works. Not financial advice.